Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Jan 31, 2018 at 11:00 AM EST

Why Cascadian Therapeutics Shares Are Skyrocketing

Cascadian Therapeutics saw its shares absolutely skyrocket on Wednesday after it was announced that Seattle Genetics would be acquiring the…

Chris Lange | Jan 31, 2018 at 8:50 AM EST

Eli Lilly Cruises Through Q4 Earnings

Eli Lilly reported better-than-expected fourth-quarter financial results before the markets opened on Wednesday.

Paul Ausick | Jan 30, 2018 at 9:30 AM EST

Amazon, Berkshire, JPMorgan Combine to Lower Health Care Costs

Three of America's best-known companies are creating an independent company with the goal to reducing costs and improving healthcare services…

Paul Ausick | Jan 30, 2018 at 7:55 AM EST

Pfizer Earnings, Guidance May Not Be Enough for Investors

Pharmaceuticals giant Pfizer beat quarterly and full-year expectations this morning, but the beats were small and the forecast for next…

Jon C. Ogg | Jan 29, 2018 at 2:05 PM EST

Can Zynerba Pharma Shares Really Still Double in These High Times?

While Zynerba's share price is still roughly half of last year's peak, the company has gotten attention from Wall Street…

Jon C. Ogg | Jan 27, 2018 at 1:25 PM EST

6 Speculative Biotech Stocks With 50% to 250% Potential Upside

This year is shaping up to be a stellar one for biotech. Investors are looking for growth and upside, and…

Chris Lange | Jan 27, 2018 at 9:20 AM EST

Top Stocks to Look For in February’s FDA Calendar

Johnson &; Johnson, Gilead Sciences and Amicus Therapeutics are among companies expecting clinical trial and FDA updates in February.

Chris Lange | Jan 26, 2018 at 8:50 AM EST

AbbVie’s Q4 Boosted by Strong Segment Results

AbbVie reported better-than-expected fourth-quarter financial results before the markets opened on Friday.

Jon C. Ogg | Jan 25, 2018 at 12:25 PM EST

Why Analysts Keep Chasing Abbott Labs Higher and Higher

24/7 Wall St. has noticed that analysts and investors seem to not be able to get enough of Abbott Laboratories.

Chris Lange | Jan 25, 2018 at 10:10 AM EST

Major Pharma Short Interest Keeps Climbing

The January 12 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 25, 2018 at 10:05 AM EST

Short Sellers Raise the Stakes in Major Biotechs

The January 12 short interest data have been compared with the previous report, and short interest moves in the selected…

Lee Jackson | Jan 25, 2018 at 10:00 AM EST

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

With the market trading at very extended valuations, and the S&P 500 on the longest streak ever without a 5%…

Chris Lange | Jan 24, 2018 at 10:50 AM EST

Why Analysts Are Slashing Their Targets for Puma Biotechnology

Puma Biotechnology saw its shares take a dive on Wednesday following regulatory events in Europe for its breast cancer treatment.

Chris Lange | Jan 24, 2018 at 9:50 AM EST

Solid Biosciences Closes in on IPO With Updated Pricing

Solid Biosciences intends to price its 7 million shares so that its initial public offering is valued up to nearly…

Chris Lange | Jan 23, 2018 at 8:55 AM EST

Johnson & Johnson Takes on $14 Billion Tax Charge With Q4 Earnings

Johnson & Johnson reported better-than-expected fourth-quarter financial results before the markets opened on Tuesday.

1 … 143 144 145 146 147 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Cascadian Therapeutics Shares Are Skyrocketing

Eli Lilly Cruises Through Q4 Earnings

Amazon, Berkshire, JPMorgan Combine to Lower Health Care Costs

Pfizer Earnings, Guidance May Not Be Enough for Investors

Can Zynerba Pharma Shares Really Still Double in These High Times?

6 Speculative Biotech Stocks With 50% to 250% Potential Upside

Top Stocks to Look For in February’s FDA Calendar

AbbVie’s Q4 Boosted by Strong Segment Results

Why Analysts Keep Chasing Abbott Labs Higher and Higher

Major Pharma Short Interest Keeps Climbing

Short Sellers Raise the Stakes in Major Biotechs

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

Why Analysts Are Slashing Their Targets for Puma Biotechnology

Solid Biosciences Closes in on IPO With Updated Pricing

Johnson & Johnson Takes on $14 Billion Tax Charge With Q4 Earnings

Is XRP About to Bounce? XRP FUD Just Hit the Same Low That Sparked a 50% Rally

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

The Fed Just Triggered a Sharp Tech-Sector Sell-Off: Here Is the 1 Dirt-Cheap Financial Disruptor I’m Buying Hand Over Fist

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

He Wants to Spend Retirement Restoring Classic Cars. How Large a Portfolio Does He Need?

Is XRP About to Bounce? XRP FUD Just Hit the Same Low That Sparked a 50% Rally

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

Health and Healthcare Articles

All Health and Healthcare Articles

Why Cascadian Therapeutics Shares Are Skyrocketing

Eli Lilly Cruises Through Q4 Earnings

Amazon, Berkshire, JPMorgan Combine to Lower Health Care Costs

Pfizer Earnings, Guidance May Not Be Enough for Investors

Can Zynerba Pharma Shares Really Still Double in These High Times?

6 Speculative Biotech Stocks With 50% to 250% Potential Upside

Top Stocks to Look For in February’s FDA Calendar

AbbVie’s Q4 Boosted by Strong Segment Results

Why Analysts Keep Chasing Abbott Labs Higher and Higher

Major Pharma Short Interest Keeps Climbing

Short Sellers Raise the Stakes in Major Biotechs

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

Why Analysts Are Slashing Their Targets for Puma Biotechnology

Solid Biosciences Closes in on IPO With Updated Pricing

Johnson & Johnson Takes on $14 Billion Tax Charge With Q4 Earnings

Is XRP About to Bounce? XRP FUD Just Hit the Same Low That Sparked a 50% Rally

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

The Fed Just Triggered a Sharp Tech-Sector Sell-Off: Here Is the 1 Dirt-Cheap Financial Disruptor I’m Buying Hand Over Fist

Featured Reads

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

He Wants to Spend Retirement Restoring Classic Cars. How Large a Portfolio Does He Need?